Page 13 - Pnt O News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pnt o. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pnt O Today - Breaking & Trending Today

POINT Biopharma Global (NASDAQ:PNT) Issues Quarterly Earnings Results, Beats Expectations By $1.79 EPS

POINT Biopharma Global (NASDAQ:PNT – Get Rating) announced its earnings results on Monday. The company reported $1.53 earnings per share for the quarter, topping the consensus estimate of ($0.26) by $1.79, MarketWatch Earnings reports. The business had revenue of $226.58 million for the quarter, compared to analysts’ expectations of $260.00 million. POINT Biopharma Global Stock […] ....

Raymond James , Principal Financial Group Inc , Biopharma Global Inc , Capital Management , Virtu Financial , Get Rating , Marketwatch Earnings , Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Stock Price Up 6.6%

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating)’s stock price was up 6.6% on Wednesday . The stock traded as high as $7.26 and last traded at $7.23. Approximately 64,745 shares changed hands during trading, a decline of 88% from the average daily volume of 560,126 shares. The stock had previously closed at $6.78. Analysts […] ....

Raymond James , Zurcher Kantonalbank Zurich Cantonalbank , Biopharma Global Inc , Point Biopharma Global Inc , Principal Financial Group Inc , Capital Management , Psagot Value Holdings Ltd , Get Rating , Global Stock , Value Holdings , Kantonalbank Zurich Cantonalbank , Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global Inc. (NASDAQ:PNT) Receives Average Recommendation of "Buy" from Brokerages

Shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating) have been assigned a consensus rating of “Buy” from the ten research firms that are presently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have covered the […] ....

Raymond James , Zurcher Kantonalbank Zurich Cantonalbank , Biopharma Global Company Profile , Psagot Value Holdings Ltd , Tudor Investment Corp Et Al , Biopharma Global Inc , E Fund Management Co , Get Rating , Value Holdings , Kantonalbank Zurich Cantonalbank , Fund Management , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Releases Quarterly Earnings Results, Beats Expectations By $1.79 EPS

POINT Biopharma Global (NASDAQ:PNT – Get Rating) issued its quarterly earnings results on Monday. The company reported $1.53 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.26) by $1.79, MarketWatch Earnings reports. The company had revenue of $226.58 million for the quarter, compared to analysts’ expectations of $260.00 million. POINT Biopharma […] ....

Raymond James , Biopharma Global Inc , Principal Financial Group Inc , Capital Management , Virtu Financial , Biopharma Global Company Profile , Get Rating , Marketwatch Earnings , Global Price , Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

Implementation of "Heritage for Yemen's Generations" project l...

Petra National Trust (PNT) kicked off implementing "Heritage for Yemen's Generations" project, aimed at introducing Yemeni school students to their country's ancient civilizations, spreading related awareness, preserving heritage and transferring its treasures from one generation to another.
....

Dana Firas , International Alliance For The Protection Of Heritage , Yemeni Ministry Of Education , Petra National Trust , Jordan News Agency , Her Highness Princess Dana Firas , Cultural Heritage , International Alliance , Conflict Areas , Yemeni Ministry , Jordan News , Syndication Bureau , Tribune Content Agency , Jordan Times ,